FDA Approved: GLATIRAMER ACETATE — Original Application (AJENAT PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approved a generic version of glatiramer acetate (AJENAT Pharmaceuticals LLC) under an original ANDA for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

ORIG AP for GLATIRAMER ACETATE (GLATIRAMER ACETATE)